Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: JT's PR was followed by the SEC filing... and this gives plenty of info....

"Shares Repurchased. Over the course of fiscal year 2007 we’ve spent over $8.8 million repurchasing shares of the Company. To date we’ve acquired more than 18 million of our own shares under a program that began back in July of 2006 when the management and the Board of Directors felt that"

Nothing new due to the fact that this information was published with the relevant SEC-filings!

I don't blame Jim on bringing out PRs, it's ok. However, we need figures and hard facts in those PR's as this is what investors want to hear or see. Confidence isn't created by PR's "detail......" without mention this detail information.

GTLA

S402005

Share
New Message
Please login to post a reply